Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-020801
Filing Date
2025-07-31
Accepted
2025-07-31 21:05:05
Documents
2
Period of Report
2025-07-29

Document Format Files

Seq Description Document Type Size
1 form4-07312025_090701.html 4  
1 form4-07312025_090701.xml 4 8018
2 ex24-07312025_090701.htm EX-24 4516
  Complete submission text file 0001415889-25-020801.txt   14144
Mailing Address C/O ALUMIS INC. 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Babler Martin (Reporting) CIK: 0001435618 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42143 | Film No.: 251173393

Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Issuer) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)